Loading, please wait...
Due to concerns about the novel coronavirus, and consistent with ongoing efforts to reduce spread of the virus, attendance for these CE sessions will be WEBINAR ONLY. Please see instructions below for registration.
PLEASE FOLLOW THE STEP-BY-STEP INSTRUCTIONS BELOW – DO NOT SKIP STEPS!
STEP 1: SIGN INTO YOUR ACCOUNT AND REGISTER FOR EACH SESSION YOU WOULD LIKE TO ATTEND
** If you do not register for the CE at this link, you will not be able to access the evaluations to earn credit
** EVERYONE must register BEFORE the session date. NO NEW REGISTRATIONS WILL BE ADDED AFTER THE PROGRAM DATE
** You will receive an email confirming your registration at the email address provided – if you do not receive a confirmation email, try to register again
**New sessions may be added throughout the month, so do not assume you are automatically registered for all sessions.
STEP 2: AFTER SUCCESSFULLY REGISTERING ON THIS SITE - AT THE TIME OF THE PROGRAM, EXPAND THE MODULE AT THE BOTTOM OF THIS PAGE AND CLICK THE WEBEX LINK.
The Link will not be emailed to you. It can only be found on this page.
** submit your contact informationSTEP 3: Collect the presenter code for each of the CEs that you attend
** EVERYONE will need the presenter codes to access evaluations and earn CE credit
STEP 4: You will receive an automated email to log in and complete evaluations
** Evaluations must be completed within 60 days of the CE session
** You will need the presenter codes to access each evaluation
** Evaluations MUST be completed within 60 days of the program date to earn CE credit!
Date: May 1, 2022 01:00 AM - May 31, 2022 11:55 PM
CE Hours
6.00
CE Units
0.600
Registration closes on May 31, 2022 12:00 AM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
Participants have 60 days from the start of their program to claim CE credit and verify it has been upload to CPE Monitor. If your program requires the completion of a post test/eval/survey those items MUST be done before that 60 day window closes to receive credit for that program. Statements of credit can be viewed and printed from CPE Monitor. Statements of credit will no longer be printed and mailed to the participant. **No partial individual session credit will be given**
PAYMENT NOTE: During the registration process, if a fee is required, please enter the zip code associated with your credit card's BILLING ADDRESS. For security purposes payments are processed through a separate system, so when prompted, please click “ok” to be taken to that site and complete your registration. Upon successful registration of this program you will receive an email confirmation/receipt and will be returned to this program page. When you are retuned to this page you will see a note at the top of the page reading “You are registered for this program.”
If you are not automatically returned to this page or see only a blank white screen your transaction was not successful, and you will need to try again.
If paying by check please mail to the address below: 301 Pharmacy Lane, CB# 7574 Beard Hall
Chapel Hill, NC 27599
|
|
|
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. To receive CE credit, participants must complete the CE attendance form and the online evaluation of the program (instructions to be emailed). Statements of credit can be viewed and printed in CPE Monitor approximately 2 to 3 weeks after the program and you have completed any needed requirements. **No partial credit will be available**
|
Co-Sponsor(s)
UNC Health System
Support/Credits
Cancelations: Cancelations must be received in writing/email to the Office of Continuing Education at least 48 hours prior to start date to receive a full refund. No refunds will be given within 48 hours of the start date.
IMPORTANT: UNC HEALTH SYSTEM EMPLOYEES AND UNC ESHELMAN SCHOOL OF PHARMACY STUDENTS ONLY
UNC Health System Employees and ESOP Students are able to attend this Resident Series at no charge to them. If you are a Health System Employee or Student please follow the steps below. This only applies to this series. Other UNC ESOP CE programs are available to register at the fee listed on that page.
- UNC Health System Employees and UNC ESOP Students should register using your UNC email address. UNC Employees - please select your employment location during the registration process. UNC Students - please respond "Yes" to the "Are you a UNC Student" question.
- Select the “Check” payment method on the registration page. Your employment will be verified prior to credit being uploaded
This session will discuss biosimilar trends in adult and pediatric populations and outline how biosimilar therapies should be utilized in practice.
Objectives
- Assess how changes in legislation, market share and spending have led to biosimilar utilization shift in the US
- Discuss the level of evidence required for biosimilar approval in adult vs pediatric populations
- Describe provider attitudes and practice impact of biosimilar use in our two populations
- Outline the current state of biosimiar use and future directions
Speaker(s)/Author(s)
|
Joanna Billings, PharmD
|
Activity Number
0046-9999-22-127-L01-P
Date:
05/05/22
Time:
04:00 PM - 05:00 PM
CE Hours
1.00
Location
Online
The session will briefly discuss acute lymphoblastic leukemia (ALL) overview and the challenges associated with ALL treatment in older adults. The audience will get a review of the evidence behind the different treatment regimens used and the limitations within each trial.
Objectives
- Review the pathophysiology of acute lymphoblastic leukemia (ALL)
- Describe the challenges with treating ALL in older adults
- Summarize the evidence surrounding common Ph-positive ALL and Ph-negative ALL for older adults
- Identify an appropriate treatment regimen for older adults with ALL
Speaker(s)/Author(s)
|
Jacqueline Dela Pena, PharmD
|
Activity Number
0046-9999-22-055-L01-P
Date:
05/12/22
Time:
03:00 PM - 04:00 PM
CE Hours
1.00
Fee
$10.00
While the number of solid organ transplants from deceased organ donors continue to rise, there is still an immense unmet solid organ transplant demand. This can be further alleviated by increasing number of organ donors through adequate management. This session will focus on necessary measures to preserve hemodynamic stability in brain-dead donors Current literature supports the role of vasoactive measures and hormone replacement therapy in brain-dead donors.
Presentation Slides available for download at the bottom of this module. You MUST be signed into your registered account to access this content
Objectives
- Discuss the unmet solid organ transplant demand and the role of deceased organ donation
- Identify appropriate interventions to preserve the hemodynamic stability of deceased organ donors
- Investigate the role of hormone replacement therapy in the pharmacologic management of organ donors
Speaker(s)/Author(s)
|
Anita Yang, PharmD
|
Activity Number
0046-9999-22-125-L01-P
Date:
05/12/22
Time:
04:00 PM - 05:00 PM
CE Hours
1.00
Fee
$10.00
Presentation Slides available for download at the bottom of this module. You MUST be signed into your registered account to access this content
Objectives
- Describe the pathophysiology of alcohol withdrawal syndrome
- Examine the role of phenobarbital as a treatment for alcohol withdrawal syndrome
- Analyze the role of dexmedetomidine and propofol as adjunct therapies to benzodiazepines for alcohol withdrawal syndrome
- Explore the use of ketamine as an adjunct therapy for alcohol withdrawal syndrome
Speaker(s)/Author(s)
|
Megan Cavagnini, PharmD
|
Activity Number
0046-9999-22-128-L04-P
Date:
05/19/22
Time:
04:00 PM - 05:00 PM
CE Hours
1.00
Location
Online
Objectives
- Describe the pathophysiology and clinical diagnosis of acute respiratory distress syndrome
- Review current evidence in management of acute respiratory distress syndrome
Speaker(s)/Author(s)
|
Emily Best, PharmD
|
Activity Number
0046-9999-22-129-L01-P
Date:
05/26/22
Time:
04:00 PM - 05:00 PM
CE Hours
1.00
Fee
$10.00
Session from 1p-2p, then repeated from 2p-3p
This session with review coagulation monitoring parameters and review current recommendations for anticoagulation monitoring, with a focus on the use of DOAC levels.
Meeting number: 2305 646 9694
Password: 3cjY7naJ42T
Objectives
- Describe the coagulation cascade, coagulation assays, and factors that can affect these labs
- Review recommended monitoring parameters for anticoagulants
- Discuss coagulation assay utilization for most common classes of anticoagulants
- Outline special populations and differences in patients taking DOACs
Speaker(s)/Author(s)
|
Michelle Yi, PharmD
|
Activity Number
0046-9999-22-131-L01-P
Date:
05/31/22
Time:
01:00 PM - 03:00 PM
CE Hours
1.00
Fee
$10.00